ConST(300445)2024-04-23 07:58Financial Performance - In Q1 2024, the company achieved revenue of CNY 107.29 million, a year-on-year increase of 0.13%[5] - Net profit attributable to shareholders was CNY 25.32 million, representing a 54.33% increase compared to the same period last year[5] - The company's cash flow from operating activities was CNY 21.08 million, a significant increase of 331.67% year-on-year[5] - Total operating revenue for Q1 2024 was CNY 107,289,043.48, a slight increase from CNY 107,154,691.45 in Q1 2023, representing a growth of approximately 0.13%[21] - Net profit for Q1 2024 reached CNY 25,010,594.70, up from CNY 17,045,530.35 in Q1 2023, indicating a significant increase of about 46.8%[23] - Basic earnings per share for Q1 2024 were CNY 0.12, up from CNY 0.08 in Q1 2023, representing a growth of 50%[23] Market Performance - The international market generated revenue of CNY 60.22 million, up 23.4% year-on-year, driven by expanded application scenarios and sustained customer orders[11] - Domestic market revenue was CNY 47.07 million, down 19.3% year-on-year, primarily due to a high growth base from Q4 2022[12] Profitability and Margins - The gross profit margin for Q1 2024 was 63.95%, an increase of 7.55% year-on-year, attributed to a higher proportion of international market revenue[12] - The company reported a gross profit margin improvement, with gross profit for Q1 2024 at CNY 68,615,383.26, compared to CNY 60,433,851.41 in Q1 2023, indicating a margin increase[21] Assets and Liabilities - Total assets at the end of the quarter were CNY 1.23 billion, a slight increase of 0.22% from the end of the previous year[5] - The company's total assets amounted to CNY 1,225,644,579.07, compared to CNY 1,222,966,978.25 in the previous year, showing a marginal increase[20] - Total liabilities decreased to CNY 95,622,468.21 from CNY 118,794,328.27, reflecting a reduction of approximately 19.4%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,270[14] - The largest shareholder, Jiang Weili, holds 16.04% of the shares, totaling 34,081,040 shares[14] - The total number of shares held by the top ten shareholders represents a significant portion of the company's equity, with the top three alone holding over 38%[14] - The total number of restricted shares held by major shareholders decreased from 74,212,770 to 70,370,760, a reduction of approximately 5.4%[16] - The company plans to release 25% of the restricted shares for Jiang Weili and He Xin on January 1, 2025[16] - The company has no preferred shareholders or changes in preferred shareholder structure reported[16] Research and Development - R&D investment for the quarter was CNY 19.83 million, a decrease of 20.2% year-on-year, accounting for 18.5% of total revenue[13] - Research and development expenses for Q1 2024 were CNY 15,179,070.03, down from CNY 17,139,820.22 in Q1 2023, a decrease of about 11.4%[21] Cash Flow and Management - The company’s cash flow from operating activities showed improvement, contributing positively to the overall financial health[24] - The net cash flow from operating activities increased to ¥21,080,615.17 from a negative ¥9,099,337.69 in the previous period, marking a significant turnaround[25] - Cash inflow from operating activities totaled ¥131,148,341.40, up from ¥104,302,429.93, representing an increase of approximately 25.8%[25] - Cash outflow from operating activities decreased to ¥110,067,726.23 from ¥113,401,767.62, indicating improved cash management[25] - The net cash flow from investing activities was negative at ¥67,372,118.23, worsening from a negative ¥28,209,158.43 in the previous period[26] - Cash inflow from investing activities decreased to ¥44,945,580.14 from ¥53,486,596.46, a decline of about 15.5%[25] - Cash outflow from investing activities increased to ¥112,317,698.37 from ¥81,695,754.89, reflecting higher investment expenditures[25] - The net cash and cash equivalents decreased by ¥47,838,103.02, compared to a decrease of ¥37,060,185.37 in the previous period[26] - The ending balance of cash and cash equivalents was ¥182,466,579.48, up from ¥176,301,300.25, showing a slight improvement[26] - The company did not report any cash inflow from financing activities during the period[26] - The impact of exchange rate changes on cash and cash equivalents was negative at ¥1,546,599.96, contrasting with a positive impact of ¥248,310.75 in the previous period[26] Future Outlook - Future outlook includes continued focus on R&D and potential market expansion strategies to enhance revenue growth[24]